Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Processa Pharmaceuticals ...

    NASDAQ: PCSA · Real-Time Price · USD
    0.33
    0.03 (9.78%)
    At close: Jun 09, 2025, 3:59 PM

    Processa Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 222.00 27.53M 12.13M
    Gross Profit
    		 n/a -222 -27.53M -12.13M
    Operating Income
    		 -12.05M -11.46M -27.53M -12.13M
    Interest Income
    		 n/a n/a 101.2K 11.99K
    Pretax Income
    		 -11.85M -11.12M -27.42M -11.96M
    Net Income
    		 -11.85M -11.12M -54.85M -11.43M
    Selling & General & Admin
    		 4.78M 5.66M 8.76M 4.69M
    Research & Development
    		 7.27M 5.8M 11.49M 6.88M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 12.05M 11.46M 20.26M 11.57M
    Interest Expense
    		 n/a n/a n/a 362.00
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 11.46M 20.26M 11.57M
    Income Tax Expense
    		 n/a n/a 27.42M -530.61K
    Shares Outstanding (Basic)
    		 3.06M 1.31M 805.46K 765.97K
    Shares Outstanding (Diluted)
    		 3.06M 1.31M 805.46K 765.97K
    EPS (Basic)
    		 -3.62 -8.48 -68 -15
    EPS (Diluted)
    		 -3.62 -8.48 -68 -15
    EBITDA
    		 -11.85M -11.46M -19.47M -11.08M
    EBIT
    		 -11.85M -11.46M -20.26M -11.96M
    Depreciation & Amortization
    		 n/a 222.00 874.01K 875.35K

    Add to Watchlist